About Nureca Technologies Private Limited
Data last updated:
Nureca Technologies Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Nureca Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33110MH2020PTC454337. Its GSTIN is 06AAHCN0260H1ZQ (Haryana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Rajinder Sharma and Aryan Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.88 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.4 Cr (net margin 6.1%) and EBITDA of ₹2.04 Cr (EBITDA margin 8.9%). Revenue has grown at a compounded annual rate (CAGR) of 458% over three years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹19.99 Cr on record. The company has 1 deal on record (1 rights issue); the latest was in March 2021.
For more details, the company can be reached via its website nureca.com.
Company details
CIN history
Nureca Technologies has one previous CIN (Corporate Identification Number): U33110PB2020PTC051368. The current CIN is U33110MH2020PTC454337, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33110MH2020PTC454337 | Current |
| U33110PB2020PTC051368 | Previous |
Contact details
Nureca Technologies Private Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Apps
- Registered AddressOffice No.101 1st Floor, Udyog Bhavan Sonawala Lane, Mumbai, Maharashtra, India – 400063
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nureca Technologies is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nureca Technologies Private Limited, buy the company report.
Financials of Nureca Technologies Private Limited
FY 2025 filings availableNureca Technologies Private Limited reported revenue of ₹22.88 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 458% over three years, including 36% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.9% | ||||
| Net Profit Margin | 6.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nureca Technologies Private Limited, buy the company report.
Board of directors of Nureca Technologies Private Limited
Nureca Technologies has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajinder Sharma Also directs: Nectar Biopharma Private Limited, Nureca Limited | Director | 31 May 2022 | 4 Years 4 Months | Current |
| Aryan Goyal Also directs: Vivaviva Private Limited, Nectar Biopharma Private Limited, Trumom Private Limited and 2 more | Director | 27 Sep 2021 | 5 Years 0 Months | Current |
| Saurabh Goyal Also directs: Nectar Biopharma Private Limited, Trumom Private Limited, Rhinobeet Private Limited and 2 more | Director | 21 Oct 2020 | 6 Years 0 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 May 2024 | 100922231 | Others | ₹19.99 Cr | Open |
To see the full charge records of Nureca Technologies Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Nureca Technologies Private Limited has 1 deal on record (1 rights issue); the latest was in March 2021.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Rights issue | ₹2.99 Cr | Investors: Nureca Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Nureca Technologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nureca Technologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nureca Technologies has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCN0260H1ZQ | Haryana | Active | 24 Jul 2020 |
| 03AAHCN0260H1ZW | Punjab | Active | 07 Aug 2020 |
To see the full GST registrations and return filing status of Nureca Technologies Private Limited, buy the company report.
Recent activity
Nureca Technologies Private Limited has 8 board changes on record since 2020: 3 appointments and 5 cessations. The latest: Rajinder Sharma ceased to be Additional Director on 30 Sep 2022.
1 earlier event is in the company report.
News
Frequently asked questions
Nureca Technologies is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 July 2020 (6+ years old) and is registered under CIN U33110MH2020PTC454337.
Nureca Technologies has 3 current directors:
- Rajinder Sharma - Director
- Aryan Goyal - Director
- Saurabh Goyal - Director
The latest financial statements of Nureca Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Nureca Technologies is 06AAHCN0260H1ZQ, registered in Haryana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 03AAHCN0260H1ZW (Punjab).
The CIN (Corporate Identification Number) of Nureca Technologies is U33110MH2020PTC454337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nureca Technologies was incorporated on 13 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Nureca Technologies has 1 deal on record (1 rights issue); the latest was in March 2021.
Rajinder Sharma ceased to be Additional Director on 30 Sep 2022. Rajinder Sharma was appointed as Director on 31 May 2022. Aryan Goyal ceased to be Additional Director on 28 Dec 2021. Nureca Technologies has 8 board changes on record in total.
Nureca Technologies can be reached through the website nureca.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Nureca Technologies is at Office No.101 1st Floor, Udyog Bhavan Sonawala Lane, Mumbai, Maharashtra, India – 400063.